MobiHealthNews

FDA meeting to weigh whether Dexcom's G5 CGM can replace fingersticks for treatment decisions

Next month the FDA is hosting a public advisory committee meeting to discuss a change to the intended use of Dexcom's G5 Mobile Continuous Glucose Monitoring System (CGM) device that would allow the ...
Medscape

FDA Okays Use of Dexcom G5 CGM for Insulin Dosing

For the first time, the US Food and Drug Administration has approved the use of a continuous glucose monitoring (CGM) system to replace finger-stick testing for determining insulin doses. The decision ...
Healio

FDA approves DexCom CGM system to replace fingerstick testing

Please provide your email address to receive an email when new articles are posted on . The FDA recently approved an expanded indication for DexCom’s G5 Mobile Continuous Glucose Monitoring System to ...
Business Wire

Tandem Diabetes Care Announces FDA Approval and Launch of t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM Integration

SAN DIEGO-- (BUSINESS WIRE)--Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced ...